z-logo
open-access-imgOpen Access
Utilization of the I nternational A ssociation for the S tudy of L ung C ancer and W ang's nodal map for the identification of mediastinum and hilar lymph nodes
Author(s) -
Xia Yang,
Ma Yun,
Arias Sixto,
Lee Hans,
Wang KoPen
Publication year - 2015
Publication title -
thoracic cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.823
H-Index - 28
eISSN - 1759-7714
pISSN - 1759-7706
DOI - 10.1111/1759-7714.12206
Subject(s) - medicine , lung cancer , lung cancer staging , mediastinum , radiology , lymph node , nuclear medicine , mediastinoscopy , oncology , pathology
Background Transbronchial needle aspiration ( TBNA ), serving as a remarkably invaluable and minimally invasive technique, has been widely used for the diagnosis and staging of mediastinal adenopathy and masses. To date, the I nternational A ssociation for the S tudy of L ung C ancer ( IASLC ) and W ang's nodal map are two well‐documented intrathoracic lymph node guidelines for the TBNA procedure. Method We characterized IASLC's and Wang's map, and interpreted the correlation of the two maps station by station. Results The pivotal role of IASLC map is to determine N descriptor in the tumor node metastasis (TNM) staging system of lung cancer, whilst Wang's map is employed to facilitate the localization of biopsy sites for bronchoscopists during TBNA performance. Furthermore, stations 1, 3 and 5 in Wang’ map are equivalent to 4R station in IASLC’ system, while stations 4 and 6 in Wang's account for IASLC station 4L as N2 stations. In addition, Wang's stations 2, 8 and 10 are correlated with station 7 in IASLC's. Wang's stations 7 and 9 are responsible for station 11R in IASLC's map. Conclusion Given their unique benefits and limitations, and the practical links between the two maps, it appears reasonable to highlight the significance of their complementary utilization upon TBNA performance and lung cancer staging.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here